Esophageal Varices clinical trials

Explore recruiting esophageal varices clinical trials.

Recruiting esophageal varices studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Esophageal Varices trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis.

Belgium, Spain, France, Germany, Poland

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Compensated Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Spain, Hungary, Netherlands, Belgium, Bulgaria, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD

Czechia, France, Netherlands, Bulgaria, Norway, Austria +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

APIS Apixaban for Intrahepatic Non Cirrhotic Portal Hypertension

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Esophageal Varices trials by city

Esophageal Varices in Toronto Esophageal Varices in Vancouver Esophageal Varices in Montreal Esophageal Varices in Calgary Esophageal Varices in Edmonton Esophageal Varices in Ottawa Esophageal Varices in Winnipeg Esophageal Varices in Quebec City Esophageal Varices in Hamilton Esophageal Varices in Kitchener Esophageal Varices in London Esophageal Varices in Halifax Esophageal Varices in New York Esophageal Varices in Los Angeles Esophageal Varices in Chicago Esophageal Varices in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease